| Solution structure of MSL2 CXC domain reveals an unusual Zn3Cys9 cluster and similarity to pre-SET domains of histone lysine methyltransferases. Zheng S., Wang J., Feng Y., Wang J., Ye K.
PLoS ONE 7:e45437-e45437(2012) · Mapped (1) |
| Usefulness of cytokeratin-19, galectin-3, and Hector Battifora mesothelial-1 in the diagnosis of benign and malignant thyroid nodules. Cui W., Sang W., Zheng S., Ma Y., Liu X., Zhang W.
Clin. Lab. 58:673-680(2012) · Mapped (10) |
| Polymorphisms of chicken Toll-like receptors 4, 15, and 21 in different breeds. Ruan W.K., Wu Y.H., An J., Zheng S.J.
Poult. Sci. 91:2512-2516(2012) · UniProtKB (19) |
| FOXC1 contributes to microvascular invasion in primary hepatocellular carcinoma via regulating epithelial-mesenchymal transition. Xu Z.Y., Ding S.M., Zhou L., Xie H.Y., Chen K.J., Zhang W., Xing C.Y., Guo H.J., Zheng S.S.
Int. J. Biol. Sci. 8:1130-1141(2012) · Mapped (5) |
| Dendritic cell-specific disruption of TGF-beta receptor II leads to altered regulatory T cell phenotype and spontaneous multiorgan autoimmunity. Ramalingam R., Larmonier C.B., Thurston R.D., Midura-Kiela M.T., Zheng S.G., Ghishan F.K., Kiela P.R.
J. Immunol. 189:3878-3893(2012) · Mapped (16) |
| Molecular cloning and functional characterization of novel antimicrobial peptides from the skin of brown frog, Rana zhenhaiensis. Xu B., Che H., Kang L., Zheng S., Mu S., Wan F.
Zool. Sci. 29:553-558(2012) · UniProtKB (10) |
| A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation. Jenkins R.B., Xiao Y., Sicotte H., Decker P.A., Kollmeyer T.M., Hansen H.M., Kosel M.L., Zheng S., Walsh K.M., Rice T. et al.
Nat. Genet. 44:1122-1125(2012) · Mapped (13) |
| Genome-wide analysis of aberrant DNA methylation for identification of potential biomarkers in colorectal cancer patients. Fang W.J., Zheng Y., Wu L.M., Ke Q.H., Shen H., Yuan Y., Zheng S.S.
Asian Pac. J. Cancer Prev. 13:1917-1921(2012) · Mapped (6) |
| Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence. Dluzniewski P.J., Wang M.H., Zheng S.L., De Marzo A.M., Drake C.G., Fedor H.L., Partin A.W., Han M., Fallin M.D., Xu J. et al.
Cancer Epidemiol. Biomarkers Prev. 21:1774-1782(2012) · Mapped (7) |
| Study of human B7 homolog 1 expression in patients with hepatitis B virus infection. Zhang W.J., Xie H.Y., Duan X., Wan Y.L., Peng C.H., Shi S.H., Su R., Zheng Z.H., Pan L.L., Zhou L. et al.
World J. Gastroenterol. 18:3681-3695(2012) · Mapped (6) |
| Inhibition of Pim-1 attenuates the proliferation and migration in nasopharyngeal carcinoma cells. Jie W., He Q.Y., Luo B.T., Zheng S.J., Kong Y.Q., Jiang H.G., Li R.J., Guo J.L., Shen Z.H.
Asian Pac J Trop Med 5:645-650(2012) · Mapped (3) |
| A miR-1231 binding site polymorphism in the 3'UTR of IFNAR1 is associated with hepatocellular carcinoma susceptibility. Zhou C., Yu Q., Chen L., Wang J., Zheng S., Zhang J.
Gene 507:95-98(2012) · Mapped (2) |
| Clinical outcomes of downregulation of E-cadherin gene expression in non-small cell lung cancer. Zheng S.Y., Hou J.Y., Zhao J., Jiang D., Ge J.F., Chen S.
Asian Pac. J. Cancer Prev. 13:1557-1561(2012) · Mapped (6) |
| The use of a combination of Ki-67, Galectin-3, and PTTG can distinguish the benign and malignant thyroid tumor. Cui W., Lu X., Zheng S., Ma Y., Liu X., Zhang W.
Clin. Lab. 58:419-426(2012) · Mapped (18) |
| TcOPT3, a member of oligopeptide transporters from the hyperaccumulator Thlaspi caerulescens, is a novel Fe/Zn/Cd/Cu transporter. Hu Y.T., Ming F., Chen W.W., Yan J.Y., Xu Z.Y., Li G.X., Xu C.Y., Yang J.L., Zheng S.J.
PLoS ONE 7:e38535-e38535(2012) · UniProtKB (1) |
| PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome. Mueller S., Phillips J., Onar-Thomas A., Romero E., Zheng S., Wiencke J.K., McBride S.M., Cowdrey C., Prados M.D., Weiss W.A. et al.
Neuro-oncology 14:1146-1152(2012) · Mapped (3) |
| Novel functional proteins interact with midkine in hepatic cancer cells. Yan Q., Huang H.L., Yao X., Li J., Li L.Q., Zhong J., Min L.S., Dai L.C., Zheng S.S.
HBPD INT 11:272-277(2012) · Mapped (4) |
| Expression of the recepteur d'originenantais receptor tyrosine kinase in non-small cell lung cancer and its clinical significance. Han W.L., Li W.D., Hu J., Rusidanmu A., Chen L.F., Shen L., Zheng S.S.
Chin. Med. J. 125:1110-1114(2012) · Mapped (5) |
| Molecular mechanisms of MMP9 overexpression and its role in emphysema pathogenesis of Smad3-deficient mice. Xu B., Chen H., Xu W., Zhang W., Buckley S., Zheng S.G., Warburton D., Kolb M., Gauldie J., Shi W.
Am. J. Physiol. Lung Cell Mol. Physiol. 303:L89-96(2012) · Mapped (11) |
| Proteomic analysis of wild-type and mutant huntingtin-associated proteins in mouse brains identifies unique interactions and involvement in protein synthesis. Culver B.P., Savas J.N., Park S.K., Choi J.H., Zheng S., Zeitlin S.O., Yates J.R., Tanese N.
J. Biol. Chem. 287:21599-21614(2012) · Mapped (6) |
| Hepatitis B virus X protein inhibits p53-mediated upregulation of mitofusin-2 in hepatocellular carcinoma cells. Wang W., Zhou D., Wei J., Wu Z., Cheng X., Sun Q., Xie H., Zhou L., Zheng S.
Biochem. Biophys. Res. Commun. 421:355-360(2012) · Mapped (5) |
| Desalting of phosphopeptides by tandem polypyrrole-c18 reverse phase micropipette tip (TMTip(PPY-C18)) based on hybrid electrostatic, Pi-Pi stacking and hydrophobic interactions for mass spectrometric analysis. Zheng S., Wang X., Fu J., Hu X., Xiao X., Huang L., Zhou Y., Zhong H.
Anal. Chim. Acta 724:73-79(2012) · Mapped (13) |
| Analysis of expressed sequence tags and characterization of a novel gene, Slmg7, in the midgut of the common cutworm, Spodoptera litura. He W.Y., Rao Z.C., Zhou D.H., Zheng S.C., Xu W.H., Feng Q.L.
PLoS ONE 7:e33621-e33621(2012) · UniProtKB (10) |
| MIF produced by bone marrow-derived macrophages contributes to teratoma progression after embryonic stem cell transplantation. Wang X., Chen T., Leng L., Fan J., Cao K., Duan Z., Zhang X., Shao C., Wu M., Tadmori I. et al.
Cancer Res. 72:2867-2878(2012) · Mapped (2) |
| Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation. Xing C., Xie H., Zhou L., Zhou W., Zhang W., Ding S., Wei B., Yu X., Su R., Zheng S.
Biochem. Biophys. Res. Commun. 420:29-35(2012) · Mapped (12) |
